| Koppel Adam |
Non-Executive Director |
Cerevel Therapeutics Holdings, Inc. (CERE)
|
2023-10-16 |
$22.81 |
97.1% |
5,480,052
|
$124,999,986 |
| Koppel Adam |
Non-Executive Director |
Cerevel Therapeutics Holdings, Inc. (CERE)
|
2020-11-09 |
$10.30 |
336.5% |
332,293
|
$3,422,618 |
| Koppel Adam |
Non-Executive Director |
Cerevel Therapeutics Holdings, Inc. (CERE)
|
2020-10-27 |
$10.00 |
349.6% |
10,000,000
|
$100,000,000 |
| Koppel Adam |
Non-Executive Director |
Aptinyx Inc. (APTX)
|
2020-01-14 |
$3.00 |
-96.8% |
3,333,333
|
$9,999,999 |
|
|
|
|
|
Return |
Profit / (loss) |
Cost |
|
|
|
Total |
|
198.3% |
$472,820,412 |
$238,422,603 |